Description
Scientific overview
RECVR is a fixed-composition, two-peptide blend supplied for laboratory research. Each vial contains BPC-157 10 mg and TB-500 10 mg, providing a total nominal peptide content of 20 mg.
BPC-157 and TB-500 are distinct research peptides commonly examined in controlled analytical, cell, and preclinical models. Findings for either component do not establish the behavior, safety, or efficacy of the fixed combination.
Research characteristics
- Molecular class: dual-peptide research blend
- BPC-157 content: 10 mg
- TB-500 content: 10 mg
- Total peptide content: 20 mg
- Blend ratio: 1:1 by nominal mass
- Evidence context: laboratory and preclinical research; this blend is not an approved clinical product
Research-use notice: Supplied for laboratory research only. Not for human or veterinary use, diagnosis, treatment, or consumption. No medical or therapeutic claims are made.
Certificate of Analysis
Every Medtruva lot ships with an independent, third-party certificate of analysis covering identity and purity. The certificate for each lot is published here and searchable by lot number.
| Compound | RECVR · MT-RECVR |
|---|
| Lot number | Assigned at first production run |
|---|
| Analytical methods | RP-HPLC (purity) · LC-MS (identity) |
|---|
| Purity | Pending lab verification |
|---|
| Testing laboratory | Independent third-party laboratory |
|---|
| Report date | Pending |
|---|
Sample certificate. Laboratory testing for the launch lots is in progress. The document below is a sample showing the format every Medtruva certificate follows; it will be replaced by the signed lab report for this lot before ordering opens.
For laboratory research only. Certificates describe the analytical results of a specific lot and are not a statement of suitability for any use.
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.